Poster Abstract Session:
65. Influenza Vaccines
Friday, October 21, 2011: 12:15 PM-2:15 PM
Room: Poster Hall B1

Topical Category: N. Hospital-acquired and surgical infections, infection control, and health outcomes including general public health and health services research

Tracks: Adult ID, Pediatric ID

Presentations:

518
Definition of a Correlate of Protection for Inactivated Influenza Vaccines in Children less than Five Years of Age: Difference Between a Seasonal Correlate and a Challenge Model
Steven Black, MD ; Uwe Nicolay, MS ; Timo Vesikari, Professor ; Marcus Knuf, MD ; Giuseppe Del Giudice, M. D. ; Giovanni della Cioppa, MD ; Theodore Tsai, MD ; Ralf Clemens ; Rino Rappuoli, MD

519
Influenza Immunization in Pregnancy and Infant Antibody at 4 Months
Julie H. Shakib, DO, MPH ; Carla M. Suarez, BS ; Andrew Pavia, MD, FIDSA ; Michael W. Varner, MD ; Michael T. Rock, PhD ; Kathryn Edwards, MD, FIDSA ; Carrie L. Byington, MD

521
Effect of Web-based Education and Nurse Champions on Employee Influenza Vaccination in an Integrated Health Care System
Justine Miranda, MD ; Michael Rothberg, MD, MPH ; Sarah Haessler, MD ; Paul Medrek, MD, MPH ; Mary Ellen Scales, RN ; Jennifer Friderici ; Amy Rist ; Paul Visintainer, PhD ; Melisha Cumberland, MD

523
Sociodemographic Correlates of Seasonal Influenza Vaccination among Health Care Workers at A Large Academic Healthcare System
Alberto Caban-Martinez, MPH ; Susanne Doblecki-Lewis, M.D. ; David Lee ; Lora Fleming, MD, PhD, MPH, MS ; Maribeth Gidley, DO ; David Lubarsky, MD, MBA ; Rafael Campo, MD

524
An 11th hour mandatory influenza healthcare worker vaccination vs mask policy
Robert Duncan, MD, MPH ; Jane Eyre Kelly, RN, CIC ; Sandra Willey, MT, CIC ; Kenneth Wener, MD ; Donald Davis ; Karen Hartford, RN

525
Persistence of Neutralizing Antibodies Following Two Doses of an AS03-adjuvanted Pandemic H1N1 Influenza Vaccine in Children Aged 6 months–17 years
Alfonso Carmona ; Juan Carlos Tejedor ; Jose Manuel Merino ; Javier Aristegui ; Jose Garcia-Sicilia ; Felix Omenaca ; Vinod Bambure ; Karl Walravens ; Ilse Dieussaert

526
Pilot Study of Elementary School-Located Influenza Vaccination, Absenteeism and Laboratory Confirmed Influenza
Edward Belongia, MD ; Sonia Kjos, PhD ; Stephanie Irving, MHS ; Jennifer Meece, PhD ; David K. Shay, MD, MPH

527
Improved Safety Profile by Different Designs of Recombinant HA-flagellin Influenza Candidate Vaccines for HA1 California/07, Novel H1N1
David Taylor, MD ; Lynda Tussey, PhD ; John J. Treanor, MD ; Theresa Fitzgerald, MS ; Uma Kavita, PhD ; Langzhou Song, PhD ; Alan Shaw, PhD ; Thomas Hofstaetter, PhD

528
Barriers to and Facilitators of Child Influenza Vaccination-Perspectives from Parents, Teens, Marketing, and Healthcare Personnel
Kavitha Bhat-Schelbert, MD, MS ; Chyongchiou Jeng Lin, PhD ; Annamore Matambanadzo, PhD ; Kristin Hannibal, MD ; Mary Patricia Nowalk, PhD ; Richard K. Zimmerman, MD MPH

532
School Based Influenza Immunization
Gina Weddle, RN, MSN ; Mary Anne Jackson, MD, FIDSA ; Nicky Spears, RN ; Kathy Hulse, RN MSN

533
A prospective randomized, open-label trial comparing the safety and efficacy of dose sparing intradermal 2010/2011 trivalent influenza vaccine delivered by two different devices
Ivan F. N. Hung, MBChB FRCP ; Yotam Levin, MD ; Kelvin K. W. To, MBBS FRCPath ; Patrick Li ; Clara Li ; Ting Xu ; Tin-Yan Wong ; Jasper FW Chan, MBBS MRCP ; Kwok-Hung Chan ; Vincent CC Cheng, MBBS (HK), FRCPath ; Kwok-Yung Yuen, MD

534
Impact Of Implementatoin Of Mandatory Influenza Vaccination Of Health Care Workers At A Tertiary Care Center: A Step in The Right Direction
Teena Chopra, MD ; Amar Krishna, MD ; Lisa Engles, MT ASCP, CIC ; MaryEllen Lesperance, RN, MSN, CHSP ; Dror Marchaim, MD ; Keith Kaye, MD, MPH, FIDSA ; Sanjay Revankar, MD ; Pranatharthi Chandrasekar, MD ; Virinia Urdaycornejo, MD ; Odaliz Abreu-Lanfranco, MD ; Jim Russel, MD ; Mark Upfal, MD ; George Alangaden, MD

535
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine (TIV) in young children 12 to 59 months of age (YC) who received AS03-adjuvanted H1N12009 pandemic vaccine; a PHAC/CIHR (PCIRN) Influenza Research Network study
Joanne Langley, MD ; David W. Scheifele, MD, FIDSA ; Caroline Quach, MD MSc FRCPC ; Otto Vanderkooi, MD ; Simon Dobson, MD ; Shelly McNeil, MD ; Donna MacKinnon-Cameron, MMath ; Brian Ward, MD ; Susan Kuhn, MD ; Tobias Kollmann, MD, PhD ; Bruce Smith, PhD ; Scott Halperin, MD ; James D. Kellner, MD

536
Receipt of Trivalent Inactivated Influenza Vaccine is Not Associated with Early Pregnancy Loss
Stephanie Irving, MHS ; Burney Kieke, MS ; James Donahue, DVM, PhD ; Maria Mascola, MD ; James Baggs, PhD ; Eric Weintraub, MPH ; Craig Cheetham, PharmD ; Jason Glanz, PhD ; Lisa A. Jackson, MD, MPH ; Allison Naleway, PhD ; James Nordin, MD, MPH ; Edward Belongia, MD

537
Children with Cancer Have Impaired Neutralization Responses to Influenza Vaccine
Lee-Ann Van De Velde, BBiomedSc(Hons) ; Hana Hakim, MD, MS ; Patricia Flynn, MD ; Jonathan A. McCullers, MD

538
Effect of Body Mass Index on Serologic Response to Influenza Vaccination in Older Adults
Laura A. Coleman, PhD ; H. Keipp Talbot, MD, MPH ; Kimberly Crimin, PhD ; Yuwei Zhu, MD, MS ; Michael T. Rock, PhD ; Jennifer Meece, PhD ; David K. Shay, MD, MPH ; Edward Belongia, MD ; Marie Griffin, MD, MPH

539
The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons
Masatoki Sato, MD ; Masahiko Katayose, MD ; Mitsuaki Hosoya, MD ; Takashi Haneda, MD ; Hideo Yamaguchi, MD ; Yukihiko Kawasaki, MD ; Peter Wright, MD

540
FluNet: Real-time Influenza Vaccine Surveillance
Melissa Stockwell, MD, MPH ; Raquel Andres, PhD ; Nadira Fernandez, MD ; Celibell Vargas, MD ; Marc Lara, PharmD ; Philip LaRussa, MD

541
Sustained High Influenza Vaccination Rates and Decreased Safety Concerns among Pregnant Women During the 2010–2011 Influenza Season
Marci Drees, MD, MS ; Barbara Tambourelli, RN ; Amy Denstman, MBA ; Robie Zent, RN ; Patty McGraw, RN, MS ; Deborah Ehrenthal, MD

542
Influenza Immunization in Older Adults: Impact of Frailty
Xu Yao, MD ; Robert Hamilton, PhD ; Sean Leng, MD, PhD

543
Immunogenicity and Safety of a High Dose Influenza Vaccine in the Elderly Compared with Fluzone® in Young Adults and the Elderly
Peter Tsang, MD ; Geoffrey Gorse, MD ; Cynthia B. Strout, MD ; Malcolm Sperling, M.D. ; Carlos DiazGranados, MD ; David Greenberg, MD ; Ayca Ozol-Godfrey ; Victoria Landolfi ; Martine Denis, DVM

544
Safety and Immunogenicity of a Quadrivalent Inactivated Influenza Vaccine (QIV) Containing Two A and Two B Strains among Persons ≥65 Years of Age
David P. Greenberg, MD, FIDSA ; Corey Robertson, MD, MPH ; H. Keipp Talbot, MD, MPH ; Michael D. Decker, MD, MPH

545
  Immunogenicity of a Heterologous H5N1 Influenza Booster Vaccine 6 or 18 Months after Primary Vaccination in Adults
Joanne Langley, MD ; Louise Frenette, MD ; Robert Jeanfreau, MD ; Laurence Chu, MD ; Shelly McNeil, MD ; Scott Halperin, MD ; Mamadou Dramé, PhD ; Louis Fries ; David Vaughn

546
Peripheral Follicular Helper T cell Numbers Correlate with Antibody Responses after Immunization with Trivalent Inactivated Influenza Vaccine (TIV)
Santiago M.C. López, MD ; Emilio Flaño, PhD ; Gerlinde Obermoser, MD ; Raj Ranganathan ; Sara Mertz ; Shelli Farley ; Adolfo Garcia-Sastre, PhD ; Randy Albrecht, PhD ; Asuncion Mejias, MD, PhD ; Octavio Ramilo, MD

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.